Use of Suvorexant for Sleep Regulation in an Adolescent with Early-Onset Bipolar Disorder

J Child Adolesc Psychopharmacol. 2019 Jun;29(5):395. doi: 10.1089/cap.2019.0029. Epub 2019 Apr 26.

Authors

Diana I Prieto¹, Asima A Zehgeer¹, Daniel F Connor¹

Affiliation

¹ Child and Adolescent Psychiatry Outpatient Clinic, Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut.

PMID: 31033344
DOI: 10.1089/cap.2019.0029

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Anticonvulsants
Antipsychotic Agents
Azepines / therapeutic use*
Bipolar Disorder* / drug therapy
Humans
Lurasidone Hydrochloride / therapeutic use
Male
Sleep Aids, Pharmaceutical / therapeutic use*
Sleep Initiation and Maintenance Disorders / drug therapy*
Triazoles / therapeutic use*
Valproic Acid / therapeutic use

Substances

Anticonvulsants
Antipsychotic Agents
Azepines
Sleep Aids, Pharmaceutical
Triazoles
suvorexant
Valproic Acid
Lurasidone Hydrochloride